Related Experiment Video
Updated: May 20, 2026

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury
Published on: September 7, 2018
Lyophilized aspirin with trehalose may decrease the incidence of gastric injuries in healthy dogs
Lee-Shuan Lin1, Yuko Kayasuga, Nobuyuki Shimohata
1Department of Veterinary Surgery, Graduate School of Agriculture and Life Science, The University of Tokyo, Tokyo, Japan.
Lyophilized aspirin/trehalose significantly reduced gastric ulceration in dogs compared to aspirin alone. This novel formulation may offer a safer way to use aspirin, preserving therapeutic levels while minimizing gastrointestinal damage.
Area of Science:
- Pharmacology
- Gastroenterology
- Biochemistry
Background:
- Aspirin is widely used but can cause gastric damage (gastropathy).
- Trehalose exhibits anti-inflammatory and cell-protective properties.
- Novel formulations are needed to mitigate aspirin-induced gastrointestinal side effects.
Purpose of the Study:
- To investigate if lyophilized aspirin/trehalose reduces aspirin-induced gastropathy in a canine model.
- To compare the severity of gastric lesions between aspirin and lyophilized aspirin/trehalose treatments.
- To assess plasma aspirin concentrations to ensure therapeutic efficacy.
Main Methods:
- A canine study involving three groups: aspirin, lyophilized aspirin/trehalose, and control.
- Gastric lesions were evaluated using gastroscopy and the modified Lanza scale.
- Plasma aspirin concentrations were measured via high-performance liquid chromatography.
Main Results:
- Lyophilized aspirin/trehalose induced significantly less gastric ulceration compared to aspirin alone.
- Therapeutic plasma concentrations of aspirin were maintained with both aspirin and lyophilized aspirin/trehalose formulations.
- The control group showed no significant gastric lesions.
Conclusions:
- Lyophilized aspirin/trehalose demonstrates a protective effect against aspirin-induced gastropathy.
- This formulation may represent a viable strategy to reduce gastrointestinal side effects of aspirin therapy.
- Further research into trehalose-based drug delivery systems is warranted.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Prevention of Further Absorption of Poison
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Oral Drug Delivery Systems: Delayed-Release Systems
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Pharmaceutical Poisoning: Treatment Strategies

